Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Evoq Remedies Ltd (EVOQ.BO)

Compare
3.0100
+0.0500
+(1.69%)
At close: 3:15:01 PM GMT+5:30
Loading Chart for EVOQ.BO
  • Previous Close 2.9600
  • Open 3.0100
  • Bid 3.0100 x --
  • Ask --
  • Day's Range 3.0100 - 3.0100
  • 52 Week Range 2.1100 - 8.2800
  • Volume 8,000
  • Avg. Volume 273,185
  • Market Cap (intraday) 74.949M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Evoq Remedies Limited engages in the marketing, trading, and distribution of pharmaceutical formulations in India. The company trades in sweeteners, such as acesulfame potassium, aspartem, dextrose, erythritol, euro vanillin powder, malodextrin, miglitol, etc.; amino acids, such as L- alanine, L-arginine, L-aspartic acid, L-carnitine, L-cystine, L-glutamic acids, L-glutamine, L-glutathione, L-glycine, L-isoleucine, LL-trytophan, L-tyrosine, L-lysine, N-acetyl, and L-andystine; excipients, which include aspartem, bronopol, cross carmellous sodium, cross povidone, ethyl olliate, hard peraffin, hpmc all grades, light liquid paraffin, mannitol, menthol crystal, etc.; neutraceuticals; and opthalamics, which include atropine sulphate, bimatoprost, brimonidine, bromfenac, cyclopentolate, dorzolamide fluoromethelone, flurbiprofen, gatifloxacin, ketorolac tromethamine, latanoprost, natamycin, nepafenac, olopatadine, sulphacetamide sodium, timolol meleate, etc. It also offers ointments, such as adapalene, allantoin, avobenzone, azealic acid, calamine, chlorocresol, cetrimide, clindamycin phoshphate, clobetasol propionate, clotrimazole, cream base, cyclosporine, fluocinolol acetonide, fusidic acid, gamabenzene, gentamycin sulphate, halobetasol, hydroquinone, etc.; and oncology drugs, such as abiraterone acetate, alfuzosin, anastrazole, axitinib, azacitidine, bicalutamide, bleomycin, bosutinib, busualphan, capcitabine, carboplatin, cisplatin, etc. It also offers anti-biotic drugs, anti-malarial drugs, anti-allergic, anti cold drugs, analgesic/ anti-pyretic, anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. In addition, it provides vitamins, dairy and spice products, sterile, active pharmaceutical ingredients, and veterinary feed products. The company was incorporated in 2010 and is based in Ahmedabad, India.

www.evoqremedies.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: EVOQ.BO

View More

Performance Overview: EVOQ.BO

Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

EVOQ.BO
0.00%
S&P BSE SENSEX (^BSESN)
1.62%

1-Year Return

EVOQ.BO
61.41%
S&P BSE SENSEX (^BSESN)
8.65%

3-Year Return

EVOQ.BO
61.41%
S&P BSE SENSEX (^BSESN)
37.12%

5-Year Return

EVOQ.BO
61.41%
S&P BSE SENSEX (^BSESN)
159.19%

Compare To: EVOQ.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVOQ.BO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    73.70M

  • Enterprise Value

    99.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    49.17

  • Price/Book (mrq)

    0.17

  • Enterprise Value/Revenue

    66.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.62%

  • Return on Assets (ttm)

    0.18%

  • Return on Equity (ttm)

    0.25%

  • Revenue (ttm)

    141.71M

  • Net Income Avi to Common (ttm)

    882k

  • Diluted EPS (ttm)

    -0.6600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.14M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -148.89M

Research Analysis: EVOQ.BO

View More

Company Insights: EVOQ.BO

Research Reports: EVOQ.BO

View More

People Also Watch